NewAmsterdam Pharma Co NV (NAMS)
25.71
+0.11
(+0.43%)
USD |
NASDAQ |
Dec 31, 16:00
25.71
0.00 (0.00%)
After-Hours: 20:00
NewAmsterdam Pharma Total Liabilities (Quarterly): 60.33M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| argenx SE | -- |
| uniQure NV | 589.98M |
| ProQR Therapeutics NV | 91.44M |
| Merus NV | 141.42M |
| Pharming Group | 199.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 439.19M |
| Shareholders Equity (Quarterly) | 378.86M |
| Current Ratio | 10.61 |